SALL4 expression was decreased after transfection with SALL4-siRNA, which in turn resulted in significant decline in proliferation of glioma cells transfected with SALL4-siRNA (P < 0.05; Fig. 3a, b). This evidence concerns the gene SALL4 and central nervous system cancer.